Table II.
Proportion of fecal ESBL-PE and nasal MRSA colonization at ICU admission
| Variables | Frequency | ESBL | p-value |
|---|---|---|---|
| Age (years) | |||
| 1–15 | 29 | 16 (51.72) | 0.873 |
| 16–30 | 47 | 25 (53.19) | |
| 31–45 | 36 | 23 (62.16) | |
| 46–60 | 47 | 24 (51.06) | |
| ≥61 | 37 | 21 (55.26) | |
| Sex | |||
| Male | 115 | 62 (53.91) | 0.893 |
| Female | 83 | 45 (54.88) | |
| Underlying diseases | |||
| Septicemia | 46 | 25 (54.35) | 0.752 |
| Kidney diseases & Respiratory diseases | 26 | 15 (57.69) | |
| Post-exploratory laparotomy | 33 | 19 (57.58) | |
| Malginant & HIV | 34 | 19 (55.88) | |
| Stroke & DM | 36 | 19 (58.33) | |
| Others | 23 | 9 (39.13) | |
| Ward before ICU admission | |||
| EMD | 71 | 40 (56.34) | 0.437 |
| Medical | 68 | 34 [41] | |
| Surgical | 47 | 25 (53.19) | |
| Pediatric | 12 | 9 (75.00) | |
| Days hospitalized before ICU admission | |||
| 1 | 119 | 63 (52.94) | 0.296 |
| 2–3 | 25 | 14 (56) | |
| 4–7 | 29 | 20 (68.97) | |
| ≥8 | 25 | 11 (44) | |
| Hospitalization in last 6 months | |||
| Yes | 53 | 24 (45.28) | 0.037 |
| No | 117 | 73 (62.39) | |
| Antibiotic use before ICU admission | |||
| Yes | 131 | 75 (57.25) | 0.285 |
| No | 67 | 33 (49.25) | |
HIV-Human immunodeficiency virus, DM-Diabetes mellitus, EMD-Emergency department, ICU-Intensive care unit.